XML 60 R36.htm IDEA: XBRL DOCUMENT v3.20.4
Earnings Per Share (Tables)
12 Months Ended
Dec. 31, 2020
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The table below sets forth the share-based awards that have been excluded from the computation of diluted earnings per share because their effect would be antidilutive:
For the Years Ended December 31,
 202020192018
Anti-Dilutive Options4,200,509 4,696,264 2,285,775 
Anti-Dilutive Restricted Stock Units2,160,727 1,282,582 — 
Anti-Dilutive Performance Share Units721,244 752,899 145,217 
Anti-Dilutive Performance Share Options— 927,268 927,268 
7,082,480 7,659,013 3,358,260 
Schedule of Earnings Per Share, Basic and Diluted
The computations for basic and diluted (loss) earnings per share are as follows:
For the Years Ended December 31,
 202020192018
Net (Loss) Income$(428,744)$31,948 $883,111 
Less: Net Income Attributable to Non-Controlling Interest55,031 112,678 86,578 
Net (Loss) Income Attributable to CNX Resources Shareholders$(483,775)$(80,730)$796,533 
Weighted-Average Shares of Common Stock Outstanding199,225,441 190,727,122 212,348,581 
Effect of Diluted Shares*— — 2,280,384 
Weighted-Average Diluted Shares of Common Stock Outstanding199,225,441 190,727,122 214,628,965 
(Loss) Earnings Per Share:
Basic$(2.43)$(0.42)$3.75 
Diluted$(2.43)$(0.42)$3.71 
*During periods in which the Company incurs a net loss, diluted weighted average shares outstanding are equal to basic weighted average shares outstanding because the effect of all equity awards is antidilutive.
Schedule of Shares of Common Stock Outstanding
Shares of common stock outstanding were as follows:
For the Years Ended December 31,
 202020192018
Balance, Beginning of Year186,642,962 198,663,342 223,743,322 
Issuance Related to Stock-Based Compensation (1)882,335 909,107 814,344 
Retirement of Common Stock (2)(4,138,527)(12,929,487)(25,894,324)
Issuance Related to CNXM Merger37,054,223 — — 
Balance, End of Year220,440,993 186,642,962 198,663,342 
(1) See Note 15 - Stock-Based Compensation for additional information.
(2) See Note 5 - Stock Repurchase for additional information.